Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT00000246
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
10
1
23
0.4
Study Details
Study Description
Brief Summary
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 2 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
10 participants
Primary Purpose:
Treatment
Official Title:
Rapid Benzodiazepine Detoxification Using Flumazenil
Study Start Date
:
Jan 1, 1993
Actual Primary Completion Date
:
Dec 1, 1994
Actual Study Completion Date
:
Dec 1, 1994
Outcome Measures
Primary Outcome Measures
- Benzodiazepine withdrawal severity []
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Please contact site for information.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Yale University, Psychiatry | New Haven | Connecticut | United States | 06519 |
Sponsors and Collaborators
- Yale University
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Scott Woods, M.D., Yale University
Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
Yale University
ClinicalTrials.gov Identifier:
NCT00000246
Other Study ID Numbers:
- NIDA-08265-1
- R01DA008265
- R01-08265-1
- NCT00000247
First Posted:
Sep 21, 1999
Last Update Posted:
Sep 8, 2016
Last Verified:
Sep 1, 2016
Keywords provided by Yale University
Additional relevant MeSH terms: